The bank rated companies like Thermo Fisher Scientific and Agilent at Buy, Illumina and PerkinElmer at Hold, and Myriad Genetics and Luminex at Sell.
Executives provided updates on their companies at the 35th Annual JP Morgan Healthcare Conference in San Francisco.
Evercore said that Hologic's recent divestiture of its blood screening business limits near-term EPS growth; Piper, however, is looking forward to 2018.
The test, which runs on Hologic's automated Panther system, was granted pre-market approval for HIV-1 viral load monitoring.
Hologic CEO Steve MacMillan said that the deal is so compelling that the firm needed to do it now.
The evidence-based guidelines for testing individuals at risk of latent or active TB infection include recommendations on interferon-gamma release and molecular assays.
Seegene will use its proprietary assay development technologies to create highly multiplexed tests for the Hologic Fusion platform.
Solid MDx revenue growth was driven primarily by sales of Aptima women's health products on the Panther and Tigris platforms.
The expanded claim for the Aptima Zika test widens the testing window for the virus to 14 days.
The new platform, called Fusion, is an addition to the Panther system and will run qPCR assays with three "mini panels" currently in the works.
In Science this week: metagenomic-based technique for determining protein structure, and more.
An academic laments the rise of narcissism in the sciences, the Guardian reports.
Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.
The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.